What question did this study set out to answer?

To evaluate the effectiveness of various antihyperglycemic therapies in preventing liver-specific events in patients with type 2 diabetes.

April 15, 2026

Hepatic Events Prevention by Antihyperglycemic Therapies and Intervention Comparisons in Type 2 Diabetes: The HEPATIC-T2DM Network Meta-analysis

Key Points

To evaluate the effectiveness of various antihyperglycemic therapies in preventing liver-specific events in patients with type 2 diabetes.
Conducted a network meta-analysis of randomized trials
Assessed different antihyperglycemic drug classes
Compared liver-specific risk reduction across therapies
Found that liver risk reduction varies significantly among antihyperglycemic drug classes
Indicated the need for further randomized trials to verify drug effects

Abstract

Liver-specific risk reduction is not uniform across antihyperglycemic drug classes. Randomized trials are needed to determine whether these associations reflect true drug effects.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Pedro Robson Costa Passos

Rodrigo Vieira Motta

Valbert Oliveira Costa Filho

Journals

Diabetes Care

Actions

Institutions

University of Oxford

Churchill Hospital

Oxford Centre for Diabetes, Endocrinology and Metabolism

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Hepatic Events Prevention by Antihyperglycemic Therapies and Intervention Comparisons in Type 2 Diabetes: The HEPATIC-T2DM Network Meta-analysis

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study

Also consider